The Duke Clinical Translational Science Institute (Duke CTSI) and North Carolina Translational and Clinical Sciences Institute (NC TraCS) are the academic homes of the National Institutes of Health’s Clinical and Translational Science Awards (CTSA) pilot funding programs at Duke University and at UNC Chapel Hill (UNC-CH). The Duke CTSI and NC TraCS are interested in promoting inter-institutional collaborations and pilot funds are now available for eligible new investigative teams.
This pilot program is designed to facilitate novel clinical, population, and translational research that applies or accelerates discovery into testing in clinical or population settings. Projects must demonstrate stakeholder engagement and a high translational potential with a clear path for continued development to move into clinical practice, generate new clinical guidelines, or other applications via subsequent grant support, new company formation, licensing, not-for-profit collaborating, an evidence base that changes practice or other channels. Duke CTSI and UNC-CH are interested in the following types of translational research projects, with an emphasis on interdisciplinary collaborations that test generalizable solutions to translational research problems:
Deadline: Nov. 18, 2019
The research award comprises a 1:1 match between Duke CTSI and NC TraCS. Duke CTSI and NC TraCS will each fund up to $25,000 direct costs, for a total of $50,000 per collaborative project. Funds will not be subcontracted from one institution to the other. UNC investigators should note that applications for this RFA with Duke do not require a financial match from your Department/School. All funds must be expended within one year of the project start date. Requests for no-cost extensions will not be approved.
